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Abstract: This paper provides an up-to-date review of intersecting know-how in engineering, medical and 
computer science frameworks. The text interweaves available measures, models, controls and technology 
for drug delivery systems in general anesthesia. The three main actors, equally important, along with 
their role in overall performance are presented and analyzed from a global perspective. The availability of 
patient information for personalized healthcare is systematically analyzed and the possibility to integrate 
this hybrid information sources into personalized patient models are critically sought. Finally, an 
important role is given to the accurate, crisp and real-time information availability in medical devices. 
Modular integration of new items is of paramount importance in terms of space, computational burden 
and number of training hours. 




Anaesthetic action at sub-cellular and cellular levels, and in 
neuronal networks within the brain and the spinal cord, 
contribute to a clinical state of unresponsiveness and 
unconsciousness that clinically represents anaesthesia 
(Schuttler and Schwilden, 2008). It is composed of numerous 
components of which sedation/hypnosis, antinociception, and 
altered autonomous reactivity are some of the prominent 
features. From the patient’s viewpoint, the crucial effects of 
general anaesthesia are absence of consciousness and absence 
of pain. This translates into particular qualities of both 
general anaesthesia and anaesthetics: 
1) sedation and reduction of voluntary responsiveness 
(hypnosis) – mental blockade; 
2) analgesia / antinociception – sensory blockade; 
3) motoric blockade to avoid movement to provide optimal 
surgical conditions (neuromuscular blockade); 
4) autonomic blockade and stress shielding by blocking 
neurovegetative and cardio circulatory responses. 
Items 3) and 4) are commonly monitored in clinical practice. 
Items 1) and 2) are difficult to separate and quantify and the 
remainder will focus on these two components. During awake 
state, the level of sedation and analgesia can be assessed by 
clinical evaluation. During general anaesthesia, with loss of 
response to stimuli, no parameter reliably indicates 
“deepening” or “lightening” of hypnosis or analgesia. Only 
unspecific surrogate parameters such as heart rate, blood 
pressure, sweating, tearing, etc, may indirectly indicate 
changes of the anaesthetic level.  
In daily clinical practice of general anaesthesia, the goal 
is an individually tailored dosing of drugs, resulting in the 
‘optimal’ anaesthetic level that is neither too light nor too 
deep. Under-dosage of anaesthetics leads to conscious 
perception or even awareness (conscious perception with 
explicit memory) during anaesthesia. As large multi-centre 
studies have shown in Scandinavia and United States, the 
incidence of this event is between 0.1% and 0.2% in an 
average population (Sandin et al, 2000; Sebel et al, 2004). 
This implies the risk of clinical consequences, e.g. pain 
flashbacks (Salomons et al, 2004). It is important to know 
that by the time of discharge from the hospital, patients may 
report that they are not suffering from any consequences of 
the awareness and yet experience consequences after a 
symptom-free interval. This latency has been reported on 
patients of the Scandinavian multi-centre study (Lemmarken 
et al, 2002).  
Besides efforts to optimize anaesthesia to shield the 
patient from stress and consequences of surgery, cost saving 
and issues of economy may be an issue for dosing strategies 
(Song et al 1998; White et al 2004). Management of 
anaesthesia aimed at early recovery of the patient has been 
addressed as so-called ‘fast track anaesthesia’, which 
nevertheless comprises much more than optimized dosing of 
anaesthetic drugs. Therefore, knowledge of the 
pharmacokinetic and pharmacodynamic properties of 
anaesthetic drugs is imperative (Glass, 1998). 
This paper provides an overview of the available 
measures and tools for obtaining a complex framework for 
optimal drug dosing system of depth of anaesthesia (DOA).  
2. ELEMENTS OF A DOA PLATFORM 
2.1 Measuring Drug Effects 
For peri-operative management of general anaesthesia 
techniques, the following main drug classes are widely used 
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in clinical practice and of particular interest: hypnotic 
(propofol, etomidate, barbiturates, ketamine, and inhaled 
anaesthetic agents), analgesic, and narcotic drugs (morphine, 
opioids), sometimes supplemented by benzodiazepines and α2 
agonists.  
Clinical mental blockade is relatively well assessed. This 
can be done using either spectral-based methods, such as the 
Bispectral Index (BIS) (Aspect Medical Systems, Norwood, 
MA, USA), or using evoked potentials (e.g. auditory) 
(Mortier et al, 1998; Dumont and Ansermino, 2013; Absalom 
et al, 2009). These indices do not directly measure 
unconsciousness or unresponsiveness. However, trough 
extensive clinical validation it is clear that these measures are 
predictive or likelihood of response, provided that the 
anaesthetic state has been induced with the drugs used to 
calibrate the electrophysiological measure (Liu et al 2011; 
Struys et al, 1998).  
Sedation is assessed using OAA/S (observers assessment 
of alertness/sedation scale), which is a standardized 
questionnaire based on a combination of observations in the 
resting patient and responses to verbal commands with 
increasing intensity (Kress et al, 2002).  
Adequacy of analgesia and antinociception during 
anaesthesia and surgery is complex. With insufficient 
analgesia/antinociception, noxious stimuli are perceived and 
lead to a subcortical stress response. With adequate 
analgesia/antinociception, the perception of a noxious 
stimulus and the subcortical stress response are blocked. With 
increasing stimulus intensity, a higher dose of analgesic 
drugs is required to reach adequate analgesia/antinociception. 
In addition, the level of analgesia is dependent on the degree 
of mental blockade (i.e. the hypnotic component of 
anaesthesia). Assessment of adequacy of antinociception is 
characteristically a stimulus-response type of measurement.  
Similar to the development of a combined EEG (auditory 
evoked potentials) index, an index composed from different 
parameters may indicate the level of antinociception 
(Luginbuhl et al, 2010). During the development of such an 
index, one must control the input (noxious stimuli) and the 
level of antinociception (level of analgesic drug) in 
individuals and measure the response to this stimulus. 
However, difficulty arises from inter—individual variability.  
2.2 Patient Models 
Clinical practice of drug delivery systems and protocols in 
DOA regulation is limited to TCI or target controlled 
infusion (open loop, no feedback information from patient 
used). Patient models which give an indication for suitable 
drug titration to the anaesthesiologist are still based on 
averaged population compartmental models (Absalom et al, 
2009; Minto et al, 1997; Schnider et al, 1981; Schnider et al, 
1998), schematically represented in Figure 1.  
Compartmental models are augmented with an extra 
‘effect-site’ compartment, to which corresponds an effect-site 
concentration (Ozcan et al 2012; Kress et al, 2002). The 
plasma is not the site where the drugs unfold their clinical 
effects. This is usually the brain, measured via EEG or 
evoked auditory potentials. Hence, the main effect at the 
brain (effect site) is delayed when compared to plasma peak 
concentration; this is represented by adding an extra 
compartment. 
 
Fig. 1. The addition of an effect site to a three-compartment model refers to 
the fact that the anaesthetic effect takes place in the brain and not in the 
plasma. The effect site is calculated as with a negligible volume. 
 
The effect site is connected to the central compartment 
by a first order process, where the constant ke0 is the rate 
constant for elimination of drug from the effect site. This 
coefficient has a large influence on the rate of rise and offset 
of drug effect, and the dose required to produce a certain drug 
effect. The volume of the site effect is neglected. The model 
in Figure 1 is represented by the following set of equations 
(Minto et al, 1997; Schnider et al, 1981; Schnider et al, 
1998): 
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where: q denote the concentrations in the various 
compartment, U - dosing scheme as a function of time; K01 - 
rate constant reflecting all processes acting to irreversibly 
remove drug from the central compartment;  K12, K13, K21, 
K31, K1e  - inter-compartmental rate constants [mg/l]; V1 - 
volume of the central compartment [l], V2 and V3 - volume of 
the peripheral compartments [l] (respectively muscle and fat).  
The drawback of these models is mainly the fact that 
specificity of the patient is lost and creates side-effects which 
either prolong patient’s hospitalisation or treatment, either 
put his life and well-being in peril. In practice, drug titration 
in anaesthesia is still an art rather than a science, given the 
numerous unknown specific dynamics of the patient’s 
response to drug effects and thus lacks a personalised 
healthcare approach. Due to this situation, a great 
responsibility lies upon the anaesthesiologist’s shoulders.  
Efforts to relieve this responsibility and aid 
anaesthesiologists in their critical and crucial decisions, and 
to avoid life-threatening situations, have led to the 
development of closed loop drug dosing control algorithms, 
including thus feedback information from patient’s current 
state. Most of these control schemes are based still on 
population models, but they are still providing improved 
performance over open loop titration protocols (Mortier et al, 
1998).  
The state-of-the-art, however, offers possibilities to 
adapt these averaged population models to the specific 
patient undergoing DOA regulation, with successful 
(although limited) clinical trials over the landscape of 
European clinical research centres. Patient models, such as 
described by (1), which take into account physiological 
aspects, drug pharmacokinetics and drug pharmacodynamics 
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have been successfully employed with control algorithms for 
better drug dosing, avoiding over- and under- dosing of the 
patient.  
An alternative approach to physiologic and 
compartmental modelling is to use parsimonious models 
which lose their link to physiology, but have the advantage of 
less number of parameters for adaptation to the specific 
patient. There are several types of such models; parsimonious 
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(2) 
with integer-order na and nb have been published in (Lemos et 
al, 2014; Rocha et al, 2014). 
The emerging non-classical concepts of fractional 
derivatives and fractional functions (in time domain) and 
fractional order impedance models (in frequency domain) 
have made the core of the original research performed in the 
last decade by few research groups (Ionescu 2012; 
Dokomuetzidis et al, 2010; Popovic et al, 2010, 2011). 
However, research is still needed to prove that these kind of 
models can improve the perception of today’s patient 
response to drug interactions. 
If one considers the patient as a black-box system into 
which an anaesthetic drug (input) is administered, and some 
output is determined as the therapeutic surrogate end-point, 
one may distinguish between the following four models of 
drug dosing: 
1. input is independent of all previous outputs and all 
previous inputs: naïve dosing; 
2. input is independent of all outputs, but may depend on 
previous inputs: TCI; 
3. input is independent of all previous inputs but may 
depend on previous outputs: naïve feedback (e.g. PID 
control); 
4. inputs depend on previous inputs and previous outputs: 
model based closed loop control (adaptive); 
5. input depends on past inputs and outputs, and predicted 
outputs: model based predictive control (possibly 
augmented with model adaptation). 
2.3 Open loop and closed loop control 
Integrated pharmacokinetic-pharmacodynamic (PK-PD) 
models have proved to be a useful mathematical framework 
to institute such drug delivery to patients. The theory of 
model-based interactive drug dosing on the basis of common 
PK-PD models is outlined and TCI is presented as a new 
anaesthetic dosing technique that has developed during the 
last two decades (Glen 1998). TCI has relevance at other 
biomedical control fields as well. For example, diabetes 
control, where the control target is to hold the patient’s blood 
glucose level in a narrow range through insulin infusion or 
anti-angiogenic targeted cancer control, where the target is to 
decrease the volume of cancer with anti-angiogenic drug 
(Szalay et al, (2014), Kovacs et al, (2014)). Whereas TCI 
presents an open-loop dosing strategy (the past output does 
not influence the future input), current research deals with the 
model based adaptive closed-loop administration of 
anaesthetics. In these systems the past output is used to adapt 
and individualize the initial PK-PD model to the patients and 
thus has an influence on future drug dosing which is based on 
the adapted model.  
Anaesthesia regarded from the aspect of drug therapy has 
a number of particularities, as compared to other medical 
specialties; to these belong: 
- duration of therapy is confined from a few minutes to a 
couple of hours and the onset of therapeutic effects such as 
loss of conscience or neuromuscular blockade should occur 
within seconds to very few minutes; 
- the effects and side-effects of the drugs used are lethal if 
special measures, e.g. artificial ventilation, are not taken; 
- the conscious response of the patient to drug delivery is not 
available and cannot be used to guide drug therapy. 
As a consequence of these particularities, it appears natural 
that a dosing strategy which requires a time-consuming 
careful titration of drug dose to drug effect is obsolete; 
instead, short-acting drugs with a quick onset of action and a 
high degree of predictability are required. Predictability in 
this context means that the laws governing the time course of 
drug action after the delivery of drug into the central 
circulation of the human body are reliable and have a 
reasonably limited inter-individual variability.  
In the past three decades blood concentrations of 
intravenous anaesthetics served as targets which give rise to 
TCI (Glass et al, 1997) systems for the delivery of 
intravenous anaesthetics. Typical control systems consist of 
five parts (see Figure 2):  
1) the patient as the system to be controlled;  
2) the response, which is considered as a measurable 
representation of the process to be controlled; 
3) a model of the input-output relationship; 
4) an adapter which could be part of the model block; 
5) a controller, linear of nonlinear. 
 
 
Fig.2. Block diagram of a model based (adaptive) closed loop system for 
automatic drug delivery. 
 
For the development of an EEG-based feedback controlled 
administration of intravenous anaesthetics one can combine 
the PK-based TCI approach with target selection as 
determined from the PD (see patents of Struys and patents of 
Grosley). The relationship between concentration and the 
measured effect can be modelled according to a nonlinear 
Hill function (Schuttler and Schwilden, 2008) or to a 
piecewise affine Hill function (Ionescu et al, 2015). In the 
past few years, model-based feedback systems using 
Bispectral Index as the EEG parameter have been 
investigated in more detail with respect to performance and 
in comparison to ‘standard clinical practice’ (Mortier et al 
1998). The conclusion was that feedback systems have the 
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economical and more patient-friendly than traditional 
approaches in clinical research.  
2.4 Safety 
The primary concern in any computerized system in health 
care is safety. In human-supervised drug delivery regulation 
systems, ventilators, dialysis, etc, safety becomes an 
especially complex and multi-faceted matter. In addition to 
mechanical and electronic hardware, such computerized 
systems incorporate advanced software implementing signal 
processing and control algorithms that are based on 
mathematical models (Zhusubaliyev et al, 2015). Therefore, 
three groups of monitoring functions have to be in place 
ensuring system component integrity and covering hardware, 
software, and mathematical models, respectively. 
The monitoring functionality has to incorporate fault 
detection, isolation, and accommodation. Furthermore, the 
overall system performance has to be monitored as a 
safeguard measure against systemic faults caused by 
malfunction in or irregular interplay between a number 
system blocks (subsystems). Measures have also to be taken 
to prevent unintended use of medical equipment as well as to 
provide guidance to medical personnel in their interaction 
with the system. 
There are several aspects of safety in monitoring 
systems: 
- fault detection; 
- fault isolation; 
- fault accommodation; 
- software safety; 
- mathematical patient model safety, and 
- function monitoring. 
Methods for detecting mechanical and electrical faults in 
system blocks fall into two groups targeting either drastic or 
incipient faults. Fault detection raises an alarm when a 
system component does not function properly. To indicate the 
reason for an alarm and pinpoint the failing component, fault 
isolation has to be used. Methods for fault isolation 
intrinsically exploit physical or analytical redundancy in the 
system. The necessity for an accurate model capturing the 
system dynamics both in normal and abnormal operation 
presents a major design challenge. 
When the reason for the fault or location thereof is 
isolated, a suitable chain of actions has to be initiated in order 
to minimize the fault impact on the system function or enable 
graceful system degradation. In medical systems, safety 
protocols dictate system shutdown on a single detected fault, 
unless the system is mission critical, e.g. a mechanical 
ventilator without backup or a pacemaker. Transfer to manual 
mode or controlled system shutdown has to be handled with 
preserved patient safety notwithstanding faults and facilitated 
by the information provided by fault isolation algorithms. 
Medical systems become increasingly software-intensive 
and implemented by means of embedded in medical devices 
and stand-alone programs. The problem of software safety 
becomes especially intricate with the arrival of parallel 
processors in medical applications as the complexity of 
programming rises significantly (Rosen and Medvedev, 
2011). 
Signal processing and control algorithms embedded in 
medical devices and systems are in most cases based on 
mathematical models. Stability and robustness of the closed 
loop control must be guaranteed at all times and patient 
safety ensures through active constraint sets. Backup loops to 
TCI or manual mode must be introduced such that risk is 
minimized with respect to patient’s safety and well-being. 
Particular attention needs to be given to the presence of time 
delays (Ionescu et al, 2011) and possible compensating 
schemes introduced (Pop et al, 2012). 
3. INTEGRATION INTO A CYBER-PHYSICAL 
PLATFORM 
Some of the main characteristics of a Decision Support 
System (DSS) are summarized below: 
1. it has to be the framework for all subsystems, this will be 
brought together the subparts 
2. it collects all necessary and/or available data from 
heterogeneous sources 
3. it contains different use-cases for all user types 
4. it is appropriate for defining patient models 
5. it is able to realize different control strategies based on 
the models 
6. it has expedient, ergonomic and suitable Graphical User 
Interface (GUI) 
7. it can be used on different platforms 
8. it should be module based 
9. it supports operation and therapy as well. 
Many DSS exists, focused to larger or specialized areas 
(e.g. Kozlovszky et al, 2014). Because usually the resources 
are limited, DSS should be a module-based, specialized 
system, but with easy expandability. Communication 
between the different subparts and external system is critical, 
as one needs to collect a lot of data from several sources; it is 
necessary communicating with medical actuators (drug 
delivery systems, etc.); the suggested action is need to be 
displayed, stored, etc.  
 
 
Fig. 3.Simplest abstraction of the system as whole 
 
As a whole, the basic requirements of the DSS from Figure 3 
is to have a set of inputs, carefully evaluated and processed, 
in order to provide some outputs with clinical relevance. 
Possible input data sources can be the following items. 
Hospital Information System (HIS). In practice, every 
medical provider has some kind of information system, where 
data are available from the patient. Because the environment 
of the DSS is typically a hospital, a suitable solution is 
enabled if the system can directly be connected with a given 
HIS. That is not a trivial task due to the numerous and not 
homogenized HISs, which are used in different hospitals 
across Europe. Usually, the HISs contain a lot of data from 
each patients (in electronic form under the name of Electronic 
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Patient Database – EPD), but in most of the cases, this data 
are not well structured or if structured, then it may not be in a 
suitable form that can be used directly (scanned document, 
pictures, medical records, etc.).  
Interaction Between Sub-Systems and Inter-connected 
Devices. Data needs to be collected from a manifold of 
monitoring and life support devices. The main problem is the 
interface variation between these devices – the medical 
providers are using different medical devices from different 
manufacturers, but if the devices came from the same 
manufacturers it can occur a difference between them (e.g. 
diversification, newer series, etc.).  
The patient. Feedback information from the patient is 
necessary in the therapy and in the operation, as well. 
Obviously, the possible data feedback during operation is 
highly reduced – in this case the feedback from the current 
state of the patient comes from diagnostic devices. At 
therapy, to assess the actual state of the patient, we have to 
accumulate the direct and indirect state indicators. Direct 
state indicators are the opinion of the patient verbally and 
automatic (even through a potentiometer like solution, or 
something similar). Indirect state indicators are the 
monitoring devices (even 24h monitoring, implanted to the 
bed, or else). These data are needed to the modeling and 
control, and DSS parts, too. 
The nursing staff. Most of data from the staff is mirroring the 
HIS, but there are subjective data or not recorded data, which 
are maybe important, too. Expertise and know-how levels of 
the staff play a major role as well and variations in handling 
protocol of critical or life-threatening situations may occur. 
The information which is produced by the DSS need to 
transform to usable data format for the users. These users can 
be medical devices (actuators, drug delivery systems, etc.) 
that get this information as a control input. With these, the 
closed-loop control for DOA regulation is realizable through 
the DSS framework (see Figure 4).  
 
Fig.4. Interacting sub-systems of DSS 
In the context of personalized healthcare (personalized 
patient models), these platforms and the patient models 
within these platforms should be customizable (Soltesz et al 
2013). There are two ways for that: manually and automated 
methods. The manual customizing methods mean that an 
environment exists where the bulk of the tuning is made by 
algorithms and the remaining “fine tuning” part is made by 
the medical staff. This is the current clinical practice. On the 
other hand, to achieve an automated way to customize patient 
healthcare, one has to introduce the concept of model 
adaptation and control auto-tuning methods. The certification 
of these tools needs to be done also in an automated way, as 
part of a system’s calibration to the patient specificity. 
The possible outputs from control subpart are output(s) 
to the DSS subsystem and output(s) to medical actuators. The 
latter is obvious – through this connection, the closed-loop 
control can be realized, as sketched in Figure 5. The control 
subpart is able to improve the efficiency of the DSS.  
 
Fig.5. Interaction of DSS in the context of closed loop control 
 
4. CHALLENGES 
In this section we present some of the challenges associated 
with the development of personalised healthcare in the 
context of drug delivery systems in general, and DOA 
regulation in special. As a general remark to the current state 
of art of DOA regulation, one should be aware of the fact 
that the development of systems which are able and are safe 
to work under daily routine conditions is several orders or 
magnitude more difficult than developing a research tool.  
The transition from state of the art to clinical practice is 
that we lack the basic requirement in assessing sensorial 
blockade; namely, the development of a reliable clinical 
reference score that remains valid once consciousness is lost. 
Apart from feedback information availability through 
sensors, one also needs to tackle the hybrid nature of the 
input sources of the DSS and their transferability to directly 
usable data.  
If closed loops are superior to manual control, one 
should expect a widespread use of such devices, which is 
obviously not the case. The reason is that this technology is 
not fully developed. So far, all the applications in clinical 
anaesthesia have been used in a research environment, and it 
has been shown that feedback systems can be very powerful 
research tools (Ionescu et al, 2011; Ionescu et al 2014).  
It still remains to be shown that closed loop systems will 
safely operate under common daily clinical conditions and 
provide better control of drug administration. To this end, 
additional research and development is needed, especially in 
two areas: 
1) sensor technology; 
2) artefact detection and elimination. 
The use of monitors in anaesthesia seems to indicate that 
redundancy could be a successful approach to tackle this 
problem because it brings focus to multi-input multi-output 
control (Rocha et al, 2014; Soltesz et al 2013, Ionescu et al 
2014).  
Advanced control strategies, such as gain adaptation 
techniques (Nino et al, 2009) or nonlinear control techniques 
(Nascu et al, 2015; Syafiie et al, 2009) could be introduced 
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